Mohammad Aref Kyyaly

About Mohammad Aref Kyyaly

Mohammad Aref Kyyaly, With an exceptional h-index of 8 and a recent h-index of 8 (since 2020), a distinguished researcher at University of Southampton, specializes in the field of Biotechnology, genetics, Molecular biology, Protein expression and purification.

His recent articles reflect a diverse array of research interests and contributions to the field:

How Does Mild Asthma Differ Phenotypically from Difficult-to-Treat Asthma?

Cytotoxic CD4+ tissue-resident memory T cells are associated with asthma severity

Comprehensive characterization of difficult-to-treat asthma reveals near absence of T2-low status

S130 Multicomponent and longitudinal analysis of patients with difficult-to-treat asthma and severe asthma reveal near absence of T2-low status

Validation and further insight into the International Severe Asthma Registry (ISAR) eosinophil gradient algorithm in the Wessex AsThma CoHort of difficult asthma (WATCH) using …

The detrimental clinical associations of anxiety and depression with difficult asthma outcomes

Phenotypes and Clinical Outcomes of Omalizumab and Mepolizumab treated Difficult Asthma patients

MicroRNAs—a promising tool for asthma diagnosis and severity assessment: a systematic review

Mohammad Aref Kyyaly Information

University

Position

Research Fellow

Citations(all)

227

Citations(since 2020)

208

Cited By

48

hIndex(all)

8

hIndex(since 2020)

8

i10Index(all)

8

i10Index(since 2020)

8

Email

University Profile Page

Google Scholar

Mohammad Aref Kyyaly Skills & Research Interests

Biotechnology

genetics

Molecular biology

Protein expression and purification

Top articles of Mohammad Aref Kyyaly

How Does Mild Asthma Differ Phenotypically from Difficult-to-Treat Asthma?

Journal of Asthma and Allergy

2023/12/31

Cytotoxic CD4+ tissue-resident memory T cells are associated with asthma severity

Med

2023/12/8

Comprehensive characterization of difficult-to-treat asthma reveals near absence of T2-low status

The Journal of Allergy and Clinical Immunology: In Practice

2023/9/1

S130 Multicomponent and longitudinal analysis of patients with difficult-to-treat asthma and severe asthma reveal near absence of T2-low status

Thorax

2022/11/1

Validation and further insight into the International Severe Asthma Registry (ISAR) eosinophil gradient algorithm in the Wessex AsThma CoHort of difficult asthma (WATCH) using …

Clinical and Experimental Allergy

2022/6

The detrimental clinical associations of anxiety and depression with difficult asthma outcomes

Journal of Personalized Medicine

2022/4/26

Phenotypes and Clinical Outcomes of Omalizumab and Mepolizumab treated Difficult Asthma patients

Authorea Preprints

2022/3/30

MicroRNAs—a promising tool for asthma diagnosis and severity assessment: a systematic review

2022/3/29

The clinical implications of Aspergillus fumigatus sensitization in difficult-to-treat asthma patients

The Journal of Allergy and Clinical Immunology: In Practice

2021/12/1

A Role for Mucolytics and Expectorants in Aiding Inhaled Therapies in Asthma?[Response To Letter]

Journal of inflammation research

2021/10/8

Asthma diagnosis and severity assessment, can microRNAs help? A pilot study

2021/9/5

Recent insights into the management of inflammation in asthma

2021/9/2

Real‐world omalizumab and mepolizumab treated difficult asthma phenotypes and their clinical outcomes

Clinical & Experimental Allergy

2021/8

Circulating miRNAs—A potential tool to identify severe asthma risk?

Clinical and Translational Allergy

2021/6

Reply to Owora et al

2021/2/1

Novel method for assessing basophil activation by measuring altered expression of membrane-bound and intracellular basogranulin stores

World Allergy Organization Journal

2020/8

Prediction models for childhood asthma: a systematic review

2020/8

See List of Professors in Mohammad Aref Kyyaly University(University of Southampton)

Co-Authors

academic-engine